RxDoctor Payments Data

David Temmermand, DO

Otolaryngology · Woodbury, NJNPI 1881007250

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,000 of the $6,179 with a category attached, or 64.7%. Medtronic accounts for 71.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $4,242 and has fallen 86.3% since, to $580 in 2025. Among otolaryngology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,179in general payments, 2019–2025

Across 49 payments — averaging $126.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Abbott$227
  • Smith+Nephew$176
  • GSK$161
  • Ascendis Pharma Endocrinology Inc$120
  • Exelixis Inc.$118
  • plus $952 from 16 others

What the payments were for

  • Speaking & faculty fees$4,00065%
  • Food & beverage$2,00332%
  • Education$1763%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,179 in reported general payments places this provider in the 90th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$200,700
Medicare patients
495
Services billed
1,235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl97$1,996
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth12$1,727
Mometasone Furoate19$1,421
Omeprazole85$1,345
Fluticasone Propionate110$1,279
Ipratropium Bromide34$1,226
Levocetirizine Dihydrochloride104$974
Nortriptyline Hcl34$701
Famotidine34$384
Montelukast Sodium33$143
Pantoprazole Sodium21$139
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen65$96
Levothyroxine Sodium14$79
Ondansetron Hcl56$77
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$76

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Woodbury

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →